IN8bio Inc.

0.27
0.00 (0.33%)
At close: Mar 03, 2025, 3:59 PM
0.25
-5.74%
Pre-market: Mar 04, 2025, 07:05 AM EST

IN8bio Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -30.01M -28.52M -14.65M -8.56M -5.13M -2.08M
Depreciation & Amortization 2.5M 1.1M 788K 88K 96K 96K
Stock-Based Compensation 4.37M 3.47M 2.19M 357K 76K 31K
Other Working Capital 777K -1.68M -1.52M 771K -48K -733K
Other Non-Cash Items n/a 4.16M 541K 368K 68K 70K
Deferred Income Tax n/a -4.16M -541K n/a n/a n/a
Change in Working Capital -204K -170K -1.84M 611K 93K -885K
Operating Cash Flow -23.34M -24.12M -13.51M -7.13M -4.8M -2.77M
Capital Expenditures -600K -3.71M -309K n/a -330K -757K
Acquisitions n/a n/a n/a n/a 686K n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -16K -309K n/a 686.00 n/a
Investing Cash Flow -600K -3.71M -309K n/a 356K -757K
Debt Repayment -798K -615K -709K 174K n/a 1.26M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 3.28M 61K -2.66M 23.84M 65K 14.47M
Financial Cash Flow 27.04M 8.99M 32.95M 24.52M 65K 8.5M
Net Cash Flow 2.85M -18.84M 19.14M 17.38M -4.38M 4.97M
Free Cash Flow -23.94M -27.83M -13.82M -7.13M -5.13M -3.53M